1,4-ジメチル-5-(4-クロロベンゾイル)-1H-ピロール-2-酢酸 化学特性,用途語,生産方法
世界保健機関(WHO)
Zomepirac, a nonsteroidal anti-inflammatory agent, was
introduced in 1979 for the treatment of rheumatic disorders and the management of
moderate to severe pain. By 1983 its use had been associated with serious allergic
reactions, including five deaths from anaphylaxis. This led to voluntary withdrawal
of the drug from markets worldwide by the major manufacturer.
1,4-ジメチル-5-(4-クロロベンゾイル)-1H-ピロール-2-酢酸 上流と下流の製品情報
原材料
準備製品